Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
1.200
-0.010 (-0.83%)
At close: Aug 28, 2026, 4:00 PM EDT
1.227
+0.027 (2.27%)
After-hours: Aug 28, 2026, 7:14 PM EDT
Spero Therapeutics Market Cap
Spero Therapeutics has a market cap or net worth of $69.88 million as of August 28, 2026. Its market cap has decreased by -37.27% in one year.
Market Cap
69.88M
Enterprise Value
21.15M
1-Year Change
-37.27%
Ranking
Category
Stock Price
$1.20
ChartMarket Cap Chart
Since November 2, 2017, Spero Therapeutics's market cap has decreased from $154.10M to $69.88M, a decrease of -54.65%. That is a compound annual growth rate of -8.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 69.90M | -46.76% |
| Dec 31, 2025 | 131.30M | 133.63% |
| Dec 31, 2024 | 56.20M | -27.86% |
| Dec 29, 2023 | 77.90M | -13.06% |
| Dec 30, 2022 | 89.60M | -82.69% |
| Dec 31, 2021 | 517.50M | -1.84% |
| Dec 31, 2020 | 527.20M | 186.68% |
| Dec 31, 2019 | 183.90M | 64.34% |
| Dec 31, 2018 | 111.90M | -33.71% |
| Dec 29, 2017 | 168.80M | 9.54% |
| Nov 2, 2017 | 154.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Elicio Therapeutics | 74.64M |
| Annovis Bio | 73.28M |
| Cardiff Oncology | 73.13M |
| MediciNova | 70.63M |
| XBiotech | 69.21M |
| Pliant Therapeutics | 68.73M |
| Champions Oncology | 68.50M |
| iBio, Inc. | 67.56M |